Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites.
Kalambokis
Georgios
G
Fotopoulos
Andreas
A
Economou
Michael
M
Tsianos
Epameinondas V
EV
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000368:Aged; D001201:Ascites / Q000188:drug therapy / Q000209:etiology* / Q000652:urine; D004359:Drug Therapy, Combination; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D006876:Hydrothorax / Q000188:drug therapy / Q000209:etiology* / Q000652:urine; D008103:Liver Cirrhosis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008879:Midodrine / Q000627:therapeutic use*; D015282:Octreotide / Q000627:therapeutic use*; D012964:Sodium / Q000652:urine*
D000316:Adrenergic alpha-Agonists; D005765:Gastrointestinal Agents; D008879:Midodrine; D012964:Sodium; D015282:Octreotide